The Coronavirus Aid, Relief and Economic Security (CARES) Act introduced new reporting requirements for drug and biological product manufacturers to notify the FDA of potential supply distributions or shortages. This webinar provides a comprehensive overview of these reporting obligations, including the types of information that must be reported, the timelines for reporting and the process for submitting reports to the FDA. Attendees will gain a clear understanding of the CARES Act reporting requirements and practical strategies for ensuring compliance.

Key Takeaways:

• Overview of the CARES Act reporting requirements for drug and biological product manufacturers
• Types of information that must be reported, including supply chain disruptions, manufacturing delays, and potential shortages
• Timelines and deadlines for reporting to the FDA
• Processes and methods for submitting reports to the FDA.

Watch the recording now to gain a clear understanding of your responsibilities and ensure your organization is meeting the requirements presented by the CARES Act.

LexisNexis Reed Tech brings clarity to innovation for businesses worldwide. We enable innovators to accomplish more by helping them make informed decisions, be more productive, comply with regulations, and ultimately achieve a competitive advantage for their business. Our Reed Tech suite of SingleSource™ for Medical Devices, SingleSource™ for Drug Products, and Navigator™ for Drug Labels enables life sciences companies to create product data management strategies and meet compliance deadlines on time. We are proud to directly support and serve these innovators in their endeavors to better humankind.